top of page

PUBLICATIONS

RECENT

8-Shogaol Inhibits Rheumatoid Arthritis through Targeting TAK1

Seongin JoSnigdha SamarpitaJi Su LeeYong Joon LeeJoe Eun SonMinju JeongJae Hwan KimSeungpyo HongSeung-Ah YooWan-Uk KimMahaboobkhan RasoolSanguine Byun. Pharmacological research: 2022; 106176. 

 

 

Fe(III)-catalyzed regioselective and faster synthesis of isocoumarins with 3-oxoalkyl moiety at C-4: Identification of new inhibitors of PDE4. B.Thirupataiah, Harshavardhan Bhuktar, Guntipally Mounika, Gangireddy Sujeevan reddy, Jetta Sandeep Kumar, Sharda Shukla, Kazi Amirul Hossain, raghavender Medishetti, Snigdha Samarpita,  Mahaboobkhan  Rasool., P.C.Jagadish, Gautham G. Shenoy, Kishore V.L.Parsa, and Manojit Pal.. Bioroganic Chemistry: 2022; 105667.

Underpinning IL-6 biology and emphasizing selective JAK blockade as the potential alternate therapeutic intervention for rheumatoid arthritis. Susmita Srivastava, and Mahaboobkhan Rasool.. Life Sciences: 2022; 120516.

 

 

 3,3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice. Manupati Srikanth, and Mahaboobkhan Rasool.. International Immunopharmacology: 2022; 108795

bottom of page